# Oppenheimer Upgrades Incyte on Growth Beyond Jakafi’s 2029 Loss of Exclusivity

By Enna Lee

Canonical URL: https://www.tokenpost.com/news/investing/44935
Published: 2026-10-30T17:17:42.000Z
Updated: 2026-10-30T17:17:42.000Z
Section: Investing

> The firm set a $144 price target, about 23% above Incyte’s Oct. 29 close.

Oppenheimer upgraded Incyte to Outperform from Market Perform, citing growth prospects beyond Jakafi’s loss of exclusivity in 2029. Jakafi is ruxolitinib.

The firm set a $144 price target, about 23% above Incyte’s Oct. 29 closing price.